Last 12 months
Inside the activity.
0 purchase rows · 4 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 4 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 07, 2026 Filed Apr 9, 2026 17:23 UTC |
Payorski LilachDirector
|
Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 7,500 | Not disclosed Strike: $6.12 | Not disclosed |
DisclosureSEC source: 0001213900-26-041864 · ownership.xml · derivative · entry 8 Payorski Lilach · CIK 0002007989 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trustee Disclosed balance after: 7,500 Underlying: Ordinary Shares · 7,500 shares Expires 2029-06-22 F1 · derivative.exercise_price: All exercise prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of April 6, 2026. F2 · price: The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award. F3 · derivative.exercise_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant. F4 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 17:23 UTC |
Payorski LilachDirector
|
GrantEmployee Stock Option (right to buy) · Derivative | 7,500 | Not disclosed Strike: $5.87 | Not disclosed |
DisclosureSEC source: 0001213900-26-041864 · ownership.xml · derivative · entry 7 Payorski Lilach · CIK 0002007989 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trustee Disclosed balance after: 7,500 Underlying: Ordinary Shares · 7,500 shares Expires 2029-06-22 F1 · derivative.exercise_price: All exercise prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of April 6, 2026. F2 · derivative.exercise_price: The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award. F2 · price: The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award. F3 · derivative.exercise_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant. F4 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 17:23 UTC |
Payorski LilachDirector
|
Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 7,500 | Not disclosed Strike: $6.12 | Not disclosed |
DisclosureSEC source: 0001213900-26-041864 · ownership.xml · derivative · entry 6 Payorski Lilach · CIK 0002007989 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trustee Disclosed balance after: 7,500 Underlying: Ordinary Shares · 7,500 shares Expires 2029-06-22 F1 · derivative.exercise_price: All exercise prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of April 6, 2026. F2 · price: The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award. F3 · derivative.exercise_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant. F4 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 17:23 UTC |
Payorski LilachDirector
|
GrantEmployee Stock Option (right to buy) · Derivative | 7,500 | Not disclosed Strike: $5.87 | Not disclosed |
DisclosureSEC source: 0001213900-26-041864 · ownership.xml · derivative · entry 5 Payorski Lilach · CIK 0002007989 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trustee Disclosed balance after: 7,500 Underlying: Ordinary Shares · 7,500 shares Expires 2029-06-22 F1 · derivative.exercise_price: All exercise prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of April 6, 2026. F2 · derivative.exercise_price: The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award. F2 · price: The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award. F3 · derivative.exercise_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant. F4 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 17:23 UTC |
Payorski LilachDirector
|
Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 7,500 | Not disclosed Strike: $6.12 | Not disclosed |
DisclosureSEC source: 0001213900-26-041864 · ownership.xml · derivative · entry 4 Payorski Lilach · CIK 0002007989 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trustee Disclosed balance after: 7,500 Underlying: Ordinary Shares · 7,500 shares Expires 2029-06-22 F1 · derivative.exercise_price: All exercise prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of April 6, 2026. F2 · price: The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award. F3 · derivative.exercise_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant. F4 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 17:23 UTC |
Payorski LilachDirector
|
GrantEmployee Stock Option (right to buy) · Derivative | 7,500 | Not disclosed Strike: $5.87 | Not disclosed |
DisclosureSEC source: 0001213900-26-041864 · ownership.xml · derivative · entry 3 Payorski Lilach · CIK 0002007989 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trustee Disclosed balance after: 7,500 Underlying: Ordinary Shares · 7,500 shares Expires 2029-06-22 F1 · derivative.exercise_price: All exercise prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of April 6, 2026. F2 · derivative.exercise_price: The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award. F2 · price: The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award. F3 · derivative.exercise_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant. F4 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 17:23 UTC |
Payorski LilachDirector
|
Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 7,500 | Not disclosed Strike: $6.12 | Not disclosed |
DisclosureSEC source: 0001213900-26-041864 · ownership.xml · derivative · entry 2 Payorski Lilach · CIK 0002007989 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trustee Disclosed balance after: 7,500 Underlying: Ordinary Shares · 7,500 shares Expires 2029-06-22 F1 · derivative.exercise_price: All exercise prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of April 6, 2026. F2 · price: The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award. F3 · derivative.exercise_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant. F4 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 17:23 UTC |
Payorski LilachDirector
|
GrantEmployee Stock Option (right to buy) · Derivative | 7,500 | Not disclosed Strike: $5.87 | Not disclosed |
DisclosureSEC source: 0001213900-26-041864 · ownership.xml · derivative · entry 1 Payorski Lilach · CIK 0002007989 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trustee Disclosed balance after: 7,500 Underlying: Ordinary Shares · 7,500 shares Expires 2029-06-22 F1 · derivative.exercise_price: All exercise prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of April 6, 2026. F2 · derivative.exercise_price: The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award. F2 · price: The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award. F3 · derivative.exercise_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant. F4 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.